What is Zejula (niraparib) for?
Buy Zejula (niraparib). Zejula (niraparib) is a drug that stops cancer cells from growing. It’s for women with ovarian, fallopian tube, or primary peritoneal cancer. These cancers come back after treatment with platinum-based chemotherapy.
It comes in capsules, each with 100mg of niraparib.
How does Zejula (niraparib) work?
PARP enzymes help fix DNA damage. Niraparib blocks these enzymes.
This stops cancer cells from living. Niraparib works even when DNA repair genes are missing, like BRCA genes.
Where has Zejula (niraparib) been approved?
Zejula (niraparib) is approved for several cancers. It was approved by:
- Food and Drug Administration (FDA), USA, March 27, 2017
- European Medical Agency (EMA), European Union, November 16, 2017
- Health Canada, June 26, 2019
- Therapeutic Goods Administration (TGA), Australia, July 1, 2019
This medicine might be approved in other places too. If you have questions, contact our support team.
Always talk to a doctor before taking any medicine. The FDA has warned about medicine quality in India.
How is Zejula (niraparib) taken?
The usual dose is:
- 300 mg (3 capsules) once daily
If you have side effects, your doctor might change your dose or stop treatment.
everyone.org is not a medical site. For full information on Zejula (niraparib), see the official prescribing information. Your doctor can give you personalized advice.
Always follow your doctor’s advice on dosage.
Are there any known side effects of Zejula (niraparib)?
Common side effects
Common side effects include:
- abnormal blood counts: thrombocytopenia, anemia, neutropenia, leukopenia
- palpitations
- gastrointestinal disorders: nausea, constipation, vomiting, abdominal pain, diarrhoea, indigestion, dry mouth
- myalgia, back pain, and arthralgia
- fatigue/asthenia
- decreased appetite, distortion of the sense of taste
- urinary tract infection
- AST/ALT elevation
- headache, dizziness,
- insomnia
- anxiety
- nasopharyngitis
- dyspnea (laboured breathing)
- cough
- rash
- hypertension.
Serious side effects
More serious side effects include:
- thrombocytopenia
- anaemia
- Myelodysplastic Syndrome/Acute Myeloid Leukemia (MDS/AML).
Use in a specific population
Zejula (niraparib) can be fatal for a fetus. It’s advised to avoid pregnancies and breastfeeding.
For a comprehensive list of side effects and adverse reactions, please refer to the official prescribing information.